3Kuklinska AM,Musial WJ,Kaminski KA,et al.Low dose rofecoxib,inflammation and prostacyclin synthesis in acute coronary syndromes.Rocz Akad Med Bialymst,2005,50:339-342.
4Paffen E,DeMaat MP.C-reaction protein in atherosclerosis:A causal factor? Cardiovasc Res,2006,71:30-39.
二级参考文献8
1Lusis AJ. Atherosclerosis. Nature, 2000. 407: 233-241.
2Zhu J, Quyyumi AA, Norman JE, et al. The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J Infect Dis, 2000,182:1583-1587.
3Meier CR, Jick SS, Derby LE, et al. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet, 1998, 351:1467-1471.
4Epsein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation, 1999, 100:e20- e 28.
5Rupprecht HJ, Blankenberg S, Bickel C, et al. impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation, 2001,104:25-31.
6Zhu J, Quyyumi AA, Norman JE, et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol, 2000,85:140-146.
7Danesh J, Whincup P, Walker M, et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ, 2000, 321:208-213.
8Whincup P, Danesh J, Walker M, et al. Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation, 2000,101:1647-1652.
